11 unknown, 4 completed, 2 not yet recruiting, 1 active not recruiting. 7 Phase 1, 5 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Unknown 4, Completed 3 |
| Phase 2 | 5 | Unknown 3, Completed 2 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Kang Stem Biotech Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Open-Label, Single-Arm Extension Study to Evaluate the Safety and Efficacy of FURESTEM-OA-Kit Inj. in Knee Osteoarthritis Patients Who Received Placebo in the K0701 Phase 2a Trial Knee Osteoarthritis | Recruiting | Kang Stem Biotech Co., Ltd. | 36 | 2026-07-20 | 2026-08-10 | |
| Long-Term Follow-up Study of Subjects With Knee Osteoarthritis Who Had Administered FURESTEM-OA Kit Inj. in K0701 Study Knee Osteoarthritis | Not yet recruiting | Kang Stem Biotech Co., Ltd. | 58 | 2023-09-14 | 2023-08-30 | |
| Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis FURESTEM-OA Kit Inj., Placebo - Knee Osteoarthritis | Phase 1 / Phase 2 | Unknown | Kang Stem Biotech Co., Ltd. | 68 | 2023-07-06 | 2023-07-14 |
| Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj Not applicable(observational study) - Atopic Dermatitis | Not yet recruiting | Kang Stem Biotech Co., Ltd. | 102 | 2022-03-27 | 2021-01-29 | |
| Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106) Dermatitis, Atopic | Active not recruiting | Kang Stem Biotech Co., Ltd. | 262 | 2021-10-05 | 2026-05-12 | |
| Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD) FURESTEM-AD® inj. 5.0 X 10^7 cells/1.5 mL, Placebo - Dermatitis, Atopic | Phase 3 | Unknown | Kang Stem Biotech Co., Ltd. | 308 | 2021-06-29 | 2021-08-13 |
| Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj. for Moderate to Severe Chronic Atopic Dermatitis FURESTEM-AD inj - Atopic Dermatitis | Phase 1 / Phase 2 | Unknown | Kang Stem Biotech Co., Ltd. | 96 | 2021-01-27 | 2022-01-11 |
| Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj(K0202) Not applicable(observational study) - Rheumatoid Arthritis | Unknown | Kang Stem Biotech Co., Ltd. | 28 | 2019-10-02 | 2022-10-10 | |
| Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients Not applicable(observational study) - Atopic Dermatitis | Unknown | Kang Stem Biotech Co., Ltd. | 99 | 2019-08-29 | 2019-09-12 | |
| Evalution the Safety and Efficacy in Atopic Dermatitis Patients Not applicable(observational study) - Atopic Dermatitis | Unknown | Kang Stem Biotech Co., Ltd. | 98 | 2019-04-05 | 2021-06-16 | |
| Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis FURESTEM-RA Inj, sterile saline - Rheumatoid Arthritis | Phase 1 / Phase 2 | Completed | Kang Stem Biotech Co., Ltd. | 33 | 2018-07-11 | 2022-10-10 |
| Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD) FURESTEM-AD Inj., Placebo - Atopic Dermatitis | Phase 3 | Completed | Kang Stem Biotech Co., Ltd. | 197 | 2018-04-25 | 2019-09-12 |
| Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis FURESTEM-CD Inj. - Psoriasis | Phase 1 | Unknown | Kang Stem Biotech Co., Ltd. | 9 | 2018-01-17 | 2018-03-14 |
| Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj. Atopic Dermatitis | Unknown | Kang Stem Biotech Co., Ltd. | 14 | 2016-07-01 | 2018-03-08 | |
| Long-term Observational Study to Evaluation the Safety of FURESTEM-RA Inj FURESTEM-RA Inj. - Rheumatoid Arthritis | Unknown | Kang Stem Biotech Co., Ltd. | 9 | 2016-06-29 | 2018-02-09 | |
| Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) stem cells - Crohn's Disease | Unknown | Kang Stem Biotech Co., Ltd. | 24 | 2015-11-01 | 2017-09-06 | |
| Safety of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis(RA) FURESTEM-RA Inj. - Rheumatoid Arthritis | Phase 1 | Completed | Kang Stem Biotech Co., Ltd. | 9 | 2014-10-01 | 2016-10-06 |
| Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) Stem cells - Crohn's Disease | Phase 1 / Phase 2 | Unknown | Kang Stem Biotech Co., Ltd. | 24 | 2014-08-01 | 2017-09-06 |
| Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD) FURESTEM-AD Inj. - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | Kang Stem Biotech Co., Ltd. | 34 | 2013-09-01 | 2016-10-06 |
Dermatitis, Atopic (9) · Arthritis, Rheumatoid (5) · Osteoarthritis, Knee (3) · Crohn Disease (2) · Inflammatory Bowel Diseases (2) · Skin Diseases (2) · Dermatitis (1) · Eczema (1) · Psoriasis (1) · Rheumatic Diseases (1)
South Korea (17)
Sang Hak Lee, professor (3) · Bakrin Yoo, professor (2) · Chanho Na, professor (2) · Cheonuk Park, professor (2) · Donghoon Lee, professor (2) · Hyunchang Ko, professor (2) · Jihyun Lee, professor (2) · Jiyoung Ahn, professor (2) · Jooyeon Ko, professor (2) · Kyoung-Ho Yoon, professor (CI) (2) · Minkyung Shin, professor (2) · Sanghyun Cho, professor (2) · Sanguk Son, professor (2) · Suk-kyun Yang (2) · Taeyoon Kim (2)